pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
onclive·May 15·1 min read
save

Prevention and personalized skin care highlighted as future direction for melanoma oncodermatology

May 15, 2026·read at onclive ↗Positive

Dr. Beth McLellan, a dermatologist, emphasizes that preventing radiation-induced skin damage is becoming a central focus in melanoma care.

She also points out the need for equitable access to scalp cooling technologies, which can reduce hair loss during treatment.

Looking ahead, McLellan envisions a more personalized oncodermatology approach that tailors skin-care strategies to individual melanoma patients.

source

This writeup was produced by pharmadog from original reporting by onclive. The original article may no longer be reachable at its published URL.

Original headline: “Prevention and Personalization Drive the Future of Oncodermatology in Melanoma”

read at onclive ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Melanoma4Dermatology2

related stories

  • 1d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 29Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancerFierce Biotech
  • Sep 22Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?STAT
  • Sep 10STAT+: Can AI save rural health care?STAT
  • Aug 25With mRNA back in the spotlight, tRNA shows potential to treat genetic diseaseFierce Biotech